APA Цитирование

Rotman, J., Mom, C. H., Jordanova, E. S., de Gruijl, T. D., & Kenter, G. G. (2018). ‘DURVIT’: A phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment. BMC Cancer.

Chicago-стиль цитирования

Rotman, J., C. H. Mom, E. S. Jordanova, T. D. de Gruijl, and G. G. Kenter. "‘DURVIT’: A Phase-I Trial of Single Low-dose Durvalumab (Medi4736) IntraTumourally Injected in Cervical Cancer: Safety, Toxicity and Effect On the Primary Tumour- and Lymph Node Microenvironment." BMC Cancer 2018.

MLA-цитирование

Rotman, J., et al. "‘DURVIT’: A Phase-I Trial of Single Low-dose Durvalumab (Medi4736) IntraTumourally Injected in Cervical Cancer: Safety, Toxicity and Effect On the Primary Tumour- and Lymph Node Microenvironment." BMC Cancer 2018.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.